SBRT en metástasis vertebrales única o múltiples: 36 Gy en 3 fracciones dadas al GTV

Bibliografía

1. AANS. Spinal Tumors. AANS 2020 [cited 2020 October 15]. Available from: Https://Www.Aans.Org/
2. Conti A, Acker G, Kluge A, et al. Decision Making In Patients With Metastasic Spine. The Role Of Minimally Invasive Treatment Modalities. Frontiers In Oncology 2019;September 19.
   DOI: 10.3389/fonc.2019.00915
3. Schiff D, O´Neill BP, Suman VJ. Spinal Epidural Metastasis As The Initial Manifestation Of Malignancy: Clinical Features And Diagnostic Approach. Neurology 1997;49(2):452-6.
   DOI: 10.1212/WNL.49.2.452
4. Kelly PD, Zuckerman SL, Than KD, et al. Metastatic Spine Disease In Lung Cancer Patients: National Patterns Of Radiation And Surgical Care. J Spine Surg 2019;5(3):320-8.
   DOI: 10.21037/jss.2019.08.11
5. Perrin RG, Laxton AW. Metastatic Spine Disease: Epidemiology, Pathophysiology, And Evaluation Of Patients. Neurosurgery Clinics Of North America 2004;15(4): 365-73.
   DOI: 10.1016/j.nec.2004.04.018
6. Kowalchuk RO, Waters MR, Richardson KM, et al. Stereotactic Radiosurgery for the Treatment Of Bulky Spine Metastases. J Neuro-Oncology 2020;148: 381-8.
   DOI: 10.1007/s11060-020-03534-4
7. Khan M, Garg R, Gui C, et al. Neuroimaging And Stereotactic Body Radiation Therapy (SBRT) For Spine Metastasis. Topics In Magnetic Resonance Imaging 2019;28(2): 85-96.
   DOI: 10.1097/RMR.0000000000000199
8. Howell DD, James JL, Hartsell WF, et al. Single-Fraction Radiotherapy Versus Multifraction Radiotherapy For Palliation Of Painful Vertebral Bone Metastases-Equivalent Efficacy, Less Toxicity, More Convenient: A Subset Analysis Of Radiation Therapy Oncology Group Trial 97-14. Cancer 2013;119(4): 888-96.
   DOI: 10.1002/cncr.27616
9. Osborn VW, Lee A, Yamada Y. Stereotactic Body Radiation Therapy. Technology In Cancer Research & Treatment 2018;17:1-15.
   DOI: 10.1177/1533033818802304
10. Ahmed KA, Satuder MC, Miller RC, et al. Stereotactic Body Radiation Therapy In Spinal Metastases. Int J Radiat Oncol Biol Phys 2012;82(5):e803-9.
    DOI: 10.1016/j.ijrobp.2011.11.036
11. Abbouchie H, Chao M, Tacey M, et al. Vertebral Fractures Following Stereotactic Body Radiotherapy For Spine Oligometastases: A Multi-Institutional Analysis Of Patient Outcomes: Clinical Oncology 2020;32(7):433-41.
12. Cox BW, Spratt DE, Lovelock M, et al. International Spine Radiosurgery Consortium Consensus Guidelines For Target Volume Definition In Spinal Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys 2012;83(5): E597-E605.
13. Benedict SH, Yenice KM, Followill D, et al. Stereotactic Body Radiation Therapy: The Report Of AAPM Task Group 101. Medical Physics 2010;37(8): 4078-101.
14. Paddick I, Lippitz I. A Simple Dose Gradient Measurement Tool To Complement The Conformity Index. J. Neurosurg 2006;105(Suppl. Dec 2006):194-201.
15. Paddick I. A Simple Scoring Ratio To Index The Conformity Of Radiosurgical Treatment Plans. Technical Note. J Neurosurg 2000;93(Suppl.3): 219-22.
16. Park HJ, Kim HJ, Won JH. Stereotactic Body Radiotherapy (SBRT) For Spinal Metastases: Who Will Benefit The Most From SBRT? Technology In Cancer Research & Treatment 2015;14(2):159-67.
17. National Cancer Institute. Common Terminology Criteria For Adverse Events (CTCAE). Maryland: National Institutes Of Health, National Cancer Institute, U.S. Departament Of Health And Human Services; 2017. Report No.: V.5.0.
18. Kaplan EL, Meier P. Nonparametric Estimation From Incomplete Observations. J Amer Statist Assoc 1958;53(282): 457-81.
19. Wilcoxon F. Individual Comparisons By Ranking Methods. Biometrics Bulletin 1945;1(6):80-3.
20. Matthews DE, Farewell VT. Using And Understanding Medical Statistics. Basel: Karger; 2007.
21. TIBCO Software Inc. Statistica Para Windows.; 2018. Available from: Https://Www.Tibco.Com/Contact-Us
22. Ito K, Nakamura N, Shimizuguchi T, et al. Appropriate Endpoints For Stereotactic Body Radiotherapy For Bone Metastasis: Classification Into Five Treatment Groups. Reports Of Practical Oncology And Radiotherapy 2020;25:150-3.
23. Ahmed KA, Stauder MC, Miller RC, et al. Stereotactic Body Radiation Therapy In Spinal Metastases. Int J Radiat Oncol Biol Phys 2011;82(5):E803-9.
24. Damast S, Wright J, Bilsky M, et al. Impact Of Dose On Local Failure Rates After Image-Guided Reirradiation Of Recurrent Paraspinal Metastases. Int J Radiat Oncol Biol Phys 2011;81(3):819-26.
25. Yamada Y, Katsoulakis E, Laufer I, et al. The Impact Of Histology And Delivered Dose On Local Control Of Spinal Metastases Treated With Stereotactic Radiosurgery. J Neurosurgery 2017;42(1):E6.
26. Garg AK, Wang XS, Shiu AS, et al. Prospective Evaluation Of Spinal Reirradiation By Using Stereotactic Body Radiation Therapy. Cancer 2011;117(15):3509-16.
27. Thibault I, Chang EL, Sheehan J, et al. Response Assessment After Stereotactic Body Radiotherapy For Spinal Metastasis: A Report From The Spine Response Assessment In Neuro-Oncology (SPINO) Group. Lancet Oncol 2015;16:595-603.
28. Daniel WW, Cross CL. Biostatistics, A Foundation For Analysis In The Health Sciences. 10th. Wiley: Ed. Hoboken; 2013.
29. Chang EL, Shiu AS, Mendel E, et al. Phase I/II Study Of Stereotactic Body Radiotherapy For Spinal Metastasis And Its Pattern Of Failure. J Neurosurgery: Spine 2007;7(2):151-60.
30. Guckenberger M, Sweeney RA, Flickinger JC, et al. Clinical Practice Of Image-Guided Spine Radiosurgery-Results From An International Research Consortium. Radiation Oncology 2011;15(6):172-83.
31. Nelson JW, Yoo DS, Sampson JH, et al. Stereotactic Body Radiotherapy For Lesions Of The Spine And Paraspinal Regions. Int J Radiat Oncol Biol Phys 2009;73(5):1369-75.
    DOI: 10.1016/j.ijrobp.2008.06.1949